Dolphin Medical Services (BSE 526504)₹7.11+4.87%Healthcare Service Provider
Dolphin Medical Services is compared with the 10 closest in size in Healthcare Service Provider (37 companies in the industry). It has a P/E of 711.0 against a peer median of 22.4, and ROCE of 0.6% against a peer median of 0.8%, and latest-quarter sales growth of 38.5% against a peer median of 24.1%. By market cap it is #4 of 11 in this set.
As of · Peer set: 10 closest in size in Healthcare Service Provider
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Transgene Biotek | 19 | — | −2.4 | −17.9 | 2.04 | 0.0 | 0 | −2 | 25.0 | — | vs BSE 526504 |
| Nidan Laboratories and Healthcare | 19 | 12.4 | 6.0 | 2.5 | 0.16 | 0.0 | 26 | 2 | −11.3 | −91.0 | vs BSE 526504 |
| Looks Health Services | 13 | — | 0.2 | 0.1 | 0.00 | 0.0 | 0 | 0 | 62.5 | — | vs BSE 526504 |
| Dolphin Medical Services | 11 | 711.0 | 0.6 | 0.4 | 0.09 | 0.0 | 1 | 0 | 38.5 | — | — |
| Family Care Hospitals | 11 | — | −25.6 | −38.4 | 0.55 | 0.0 | 0 | −9 | 300.0 | — | vs BSE 526504 |
| Dhanvantri Jeevan Rekha | 9 | 22.4 | 3.9 | 3.9 | 0.00 | 0.0 | 26 | 0 | 24.1 | 675.0 | vs BSE 526504 |
| Boston Commerce | 8 | — | 0.1 | −10.3 | 0.18 | 0.0 | 0 | −1 | −100.0 | — | vs BSE 526504 |
| Clinitech Laboratory | 7 | 16.4 | 7.2 | 4.7 | 0.06 | 0.0 | 9 | 0 | 6.0 | −27.8 | vs BSE 526504 |
| Dr Lalchandani Labs | 6 | 107.8 | 0.8 | 0.5 | 0.15 | 0.0 | 4 | 0 | −8.6 | −146.2 | vs BSE 526504 |
| Ashram Online.com | 5 | — | 0.8 | −1.2 | 0.32 | 0.0 | 0 | −0 | 25.0 | — | vs BSE 526504 |
| Gian Lifecare | 4 | — | 2.4 | −0.2 | 0.31 | 0.0 | 6 | −0 | −29.7 | −73.5 | vs BSE 526504 |
| Peer median | 9 | 22.4 | 0.8 | 0.1 | 0.16 | 0.0 | 1 | 0 | 24.1 | −73.5 |
Listed companies closest to Dolphin Medical Services in Healthcare Service Provider include Transgene Biotek, Nidan Laboratories and Healthcare, Looks Health Services, Family Care Hospitals, Dhanvantri Jeevan Rekha, Boston Commerce, Clinitech Laboratory, Dr Lalchandani Labs.
Transgene Biotek, with a market cap of ₹19.10 Cr.
Dolphin Medical Services trades at a P/E of 711.0; the median of its peer set is 22.4. A P/E above or below the median is a description, not a judgement on value.
Dolphin Medical Services' return on capital employed is 0.6%, below the peer median of 0.8%.